全文获取类型
收费全文 | 333篇 |
免费 | 27篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 20篇 |
妇产科学 | 4篇 |
基础医学 | 54篇 |
口腔科学 | 28篇 |
临床医学 | 30篇 |
内科学 | 76篇 |
皮肤病学 | 11篇 |
神经病学 | 4篇 |
特种医学 | 57篇 |
外科学 | 32篇 |
综合类 | 9篇 |
预防医学 | 6篇 |
药学 | 15篇 |
1篇 | |
肿瘤学 | 12篇 |
出版年
2022年 | 1篇 |
2021年 | 3篇 |
2020年 | 2篇 |
2019年 | 1篇 |
2018年 | 3篇 |
2017年 | 3篇 |
2016年 | 6篇 |
2015年 | 19篇 |
2014年 | 14篇 |
2013年 | 17篇 |
2012年 | 10篇 |
2011年 | 8篇 |
2010年 | 21篇 |
2009年 | 10篇 |
2008年 | 5篇 |
2007年 | 5篇 |
2006年 | 3篇 |
2005年 | 6篇 |
2004年 | 3篇 |
2001年 | 8篇 |
2000年 | 1篇 |
1999年 | 6篇 |
1998年 | 20篇 |
1997年 | 19篇 |
1996年 | 29篇 |
1995年 | 15篇 |
1994年 | 21篇 |
1993年 | 13篇 |
1992年 | 3篇 |
1991年 | 2篇 |
1990年 | 5篇 |
1989年 | 4篇 |
1988年 | 14篇 |
1987年 | 4篇 |
1986年 | 6篇 |
1985年 | 10篇 |
1984年 | 5篇 |
1983年 | 8篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1980年 | 3篇 |
1979年 | 3篇 |
1978年 | 1篇 |
1977年 | 7篇 |
1976年 | 4篇 |
1975年 | 3篇 |
1963年 | 1篇 |
1961年 | 1篇 |
排序方式: 共有361条查询结果,搜索用时 0 毫秒
221.
222.
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence <Emphasis Type="Italic">in situ</Emphasis>hybridization and immunohistochemistry 下载免费PDF全文
Marta?SalidoEmail author Ignasi?Tusquets Josep?M?Corominas Marta?Suarez Blanca?Espinet Cristina?Corzo Xavier?Fabregat Sergi?Serrano Francesc?Solé 《Breast cancer research : BCR》2004,7(2):R267
Introduction
One of the most common genetic aberrations associated with breast cancer is the amplification and overexpression of the ERBB2 proto-oncogene located at chromosome 17, bands q12-21. The amplification/overexpression occurs in 25 to 30% of all breast cancers. In breast cancer, aneusomy of chromosome 17, either monosomy or polysomy, is frequently observed by conventional cytogenetics and fluorescence in situ hybridization (FISH). The aim of this study was to discover whether or not numerical aberrations on chromosome 17 have a correlation to the amplification or overexpression of the ERBB2 gene and to analyze their clinical implications in subgroups showing 2+ or 3+ positive scores by immunohistochemistry (IHC). 相似文献223.
224.
225.
226.
227.
p53 mutation is associated with progression in follicular lymphomas 总被引:15,自引:4,他引:15
The majority of low-grade follicular lymphomas will eventually transform to an aggressive intermediate, or high-grade lymphoma. The molecular mechanisms responsible for this transformation have not been determined. We studied serial biopsies from 34 patients with follicular lymphomas that underwent histologic transformation, for abnormalities of the p53 tumor suppressor gene by a combination of immunohistochemistry, single strand conformation polymorphism analysis (SSCP), and sequencing. We found overexpression of p53 in 10 of the 34 transformed aggressive lymphomas, 9 of which contained mutations identified by SSCP analysis and subsequent sequencing. Matched pretransformation low-grade follicular lymphoma biopsies were available for 7 of the 10 cases. None of six studied by immunohistochemistry showed overexpression of p53 and only 1 of 4 studied by SSCP/sequencing showed the presence of mutation in the pretransformation biopsy. Interestingly, an eighth p53 positive transformed lymphoma recurred with a clonally related, p53 negative low-grade lymphoma 5 years after the patient had achieved a complete remission. Immunohistochemistry also showed that several pretransformation biopsies from p53 positive transformed cases showed rare p53 positive cells and in one case we could document an increase in their number over time. Twenty-five additional low-grade follicular lymphoma biopsies were also examined. Three patients had lymphomas positive for p53 mutation. One of the three subsequently transformed within a year of the biopsy studied; the second patient had an earlier (unavailable) biopsy at a different site that showed transformed histology. The third patient was treated with ProMACE-MOPP combination chemotherapy and attained a complete remission. We conclude that (1) mutations of p53 are associated with histologic transformation in approximately 25% to 30% of follicular lymphomas and (2) p53 positive cells can be detected before histologic transformation, but do not comprise a significant percentage of the neoplastic cell population (identifiable by SSCP) until late in the disease, just before or after histologic progression. Finally, the data also suggest that p53 positive low-grade lymphomas are at risk for progression and that in this subset, aggressive therapy may be warranted. 相似文献
228.
229.
Ryanodine and inositol triphosphate receptors modulate facilitation and tetanic depression at the frog neuromuscular junction 下载免费PDF全文
230.